Cancer
Purdue Researchers Edge Closer to Delivering Personalized Medicine to Cancer Patients
Friday, February 9th, 2024 - Chemotherapy can save lives, but often a cancer patient may be resistant to their prescribed chemotherapy, which costs the patient valuable time. Chemoresistance is a topic that researchers need to understand better so that they can match the right type of chemo to the right patient, which is called personalized medicine. An unusual pairing of veterinary scientists and physicists believe their method of detecting chemoresistance could be the new standard for personalized medicine.
Study Led by Purdue Veterinary Oncologist Finds Exposure to Cigarette Smoke Increases Cancer Risk in Dogs
Friday, January 12th, 2024 - Dogs are humans’ best friends. Need to quickly locate a bomb? There’s a dog for that. Can’t see very well? There’s a dog for that. Searching for a lost hiker in the mountains or survivors in an earthquake, diagnosing illness, comforting the bereft — there are dogs for every need. They are even helping humans track down the causes of cancer. A new study led by Dr. Deborah Knapp, Distinguished Professor of Comparative Oncology, links cigarette smoke exposure to an exponentially higher rate of bladder cancer in Scottish terriers. By assessing individual dogs and studying their medical history, scientists are beginning to untangle the question of who gets cancer and why, and how best to detect, treat and prevent cancer.
Discovery Points to New Approach to Treating Liver Cancer
Friday, December 15th, 2023 - A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer patients for only two to three months. A study of the relationship between the enzyme DDX5, liver cancer and sorafenib, published in the Nature journal Cell Death & Disease, points to the potential for a more effective therapy that combines existing anti-cancer drugs with treatments that spur production of this enzyme.
VCS Professor is Involved in New Pediatric Cancer Research Center Named for Tyler Trent
Friday, October 27th, 2023 - The recently announced Tyler Trent Pediatric Cancer Research Center within the Purdue Institute for Cancer Research has a strong tie to the Purdue University College of Veterinary Medicine through a faculty member in the Department of Veterinary Clinical Sciences – Dr. Michael Childress. The new center is named in memory of the former graduate and devoted Boilermaker football fan who passed away more than four years ago from the rare bone cancer osteosarcoma. The center will be home to research to cure the disease that claimed Tyler’s life and other pediatric cancers.
Team Led By PVM Scholar Pioneers AI Application and Use of Large Canine Database to Advance Cancer Genetics Research
Friday, September 15th, 2023 - A Purdue University study’s novel use of an artificial intelligence model has revealed that biological pathways leading to cancer in dogs and humans are more similar than previously known. The research, led by Dr. Nadia Lanman, research associate professor in the College of Veterinary Medicine’s Department of Comparative Pathobiology, demonstrates enhanced value in studying naturally occurring cancer in dogs to learn more about how to defeat cancer in humans.
Purdue Comparative Oncology Research Center Named for Evan and Sue Ann Werling
Monday, June 19th, 2023 - The Purdue University College of Veterinary Medicine now is home to a named center for comparative oncology research that will advance cancer research benefiting pets and humans. The Purdue University Board of Trustees approved the naming of the Evan and Sue Ann Werling Comparative Oncology Research Center in recognition of the donors’ $10 million gift. As a part of the College of Veterinary Medicine, the center will partner with the Purdue Institute for Cancer Research.
Purdue Challenge 5K was Personal for PVM Participants Who Helped Raise $100K for Cancer Research
Friday, May 26th, 2023 - The 15th annual Purdue Challenge 5K run/walk benefiting the Purdue University Institute for Cancer Research had special meaning this year for a group of participants with ties to the Purdue University College of Veterinary Medicine. Several members of the PVM community ran in the event Saturday, April 15 to honor and celebrate the life of a cancer victim who was married to a veterinary nurse in the Evan and Sue Ann Werling Comparative Oncology Research Center. Their effort was both thoughtful and helpful, as the fundraising event raised a total of $100,000 for efforts to pursue a cure.
PVM Professor Timothy Ratliff Leads Purdue Team of Scholars in New Cancer Research Effort
Friday, May 26th, 2023 - The Purdue University Institute for Cancer Research is beginning a four-pronged attack against multiple myeloma to be carried out over two years with $4.3 million from the Paula and Rodger Riney Foundation, and Distinguished Professor of Comparative Pathobiology Timothy Ratliff is leading the team of scientists doing the research. Dr. Ratliff is the former director of Purdue’s cancer research center.
PVM and BME Scholars Team-up to Pursue Affordable Cervical Cancer Test with Life-preserving Promise
Friday, February 3rd, 2023 - Cervical cancer killed 342,000 women around the world in 2020. According to the World Health Organization, the vast majority of these women — about 90% — lived in low- and middle-income countries where access to testing for early detection is either unaffordable or nonexistent. Professor of Comparative Pathobiology Sulma Mohammed in the Purdue University College of Veterinary Medicine, and Purdue’s Marta E. Gross Associate Professor of Biomedical Engineering Jacqueline Linnes are determined to save lives by developing a low-cost, point-of-care paper test that could revolutionize cervical cancer detection worldwide.
Man’s Best Friend Leads the Way to Early Cancer Detection in Study Directed by Purdue Veterinary Scholar
Friday, December 2nd, 2022 - A canine cancer scientist at the Purdue University College of Veterinary Medicine is working to take the first steps to make a serious form of cancer in dogs — one with analogues to human health — easier to detect and treat before it has become more advanced.
